Diltiazem (DTZ) is an optically active calcium channel blocker having a benzodiazepine structure. The drug used in therapy is (+)-cis-diltiazem with configuration (2S,3S). To describe the analytical profile of DTZ different stationary phases (RP-18, RP-8, monolithic support) were tested. The best separation of DTZ from A, B, E and F was obtained using as stationary phase a RP-8 or a monolithic RP-18. The characterization of impurities was carried out using two analytical systems, HPLC and HPLC/MS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jpba.2004.11.050 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!